Logan Ridge Finance (LRFC) Q1 2025 earnings summary

Executive summary

• Net asset value per share declined to $29.66 as of March 31, 2025, from $32.04 at year-end 2024, reflecting a net decrease in net assets from operations of $5.4 million for the quarter, mainly due to an $8.8 million unrealized depreciation and a $4.4 million write-down on Sequoia Healthcare.

• Net investment income for Q1 2025 was $0.9 million ($0.35 per share), unchanged year-over-year but down from $1.5 million ($0.56 per share) in Q4 2024.

• Portfolio consisted of 59 companies with a fair value of $169.6 million, down from $172.3 million at year-end 2024.

• Successfully exited a major non-yielding equity investment, reducing legacy equity portfolio to 10.8% of fair value.

• Announced a merger agreement with Portman Ridge Finance Corporation, with LRFC shareholders to receive 1.50 PTMN shares per LRFC share, subject to shareholder approval.

Financial highlights

• Total investment income for Q1 2025 was $4.6 million, down from $5.4 million in Q4 2024 and $5.0 million in Q1 2024.

• Net deployment of $2.7 million in new and existing investments during the quarter, with $15.1 million in new investments and $12.4 million in repayments/sales.

• Cash and cash equivalents were $5.1 million at quarter-end, down from $15.0 million at the end of Q4 2024.

• Operating expenses were $3.7 million, down from $4.1 million in Q1 2024.

• Quarterly distribution of $0.36 per share declared for Q2 2025, payable May 29, 2025.

Outlook and guidance

• Management expects continued earnings growth and long-term value creation as the legacy equity portfolio is monetized.

• The proposed merger with Portman Ridge is anticipated to deliver scale, liquidity, and operational efficiencies, pending shareholder approval.

• Focus remains on direct origination of senior secured debt and reducing non-income generating exposure.